Competitive Affinity Release for Long-Term Delivery of Antibodies from Hydrogels

被引：35
作者：
Huynh, Vincent [1 ]
Wylie, Ryan G. [1 ]
机构：
[1] McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W ABB 261A, Hamilton, ON L8S 4M1, Canada
来源：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2018年 / 57卷 / 13期
基金：
加拿大自然科学与工程研究理事会; 加拿大创新基金会;
关键词：
antibodies; competitive interactions; drug delivery; materials science; protein modifications; GROWTH-FACTOR DELIVERY; FUNCTIONALIZED HYDROGELS; INJECTABLE HYDROGELS; SUSTAINED-RELEASE; IN-VITRO; HEPARIN; BINDING; SYSTEMS; BIOTIN; VEGF;
D O I：
10.1002/anie.201713428
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
With increased clinical use of antibodies, long-term delivery strategies are needed to decrease injection frequency and improve health outcomes. A three-component drug-delivery system was developed for competitive affinity release of a streptavidin-antibody conjugate from agarose-desthiobiotin hydrogels via controlled dissolution of sparingly soluble biotin derivatives. The antibody conjugate was localized in the hydrogel through streptavidin-desthiobiotin complexation. Dissolution of sparingly soluble biotin derivatives disrupts streptavidin-desthiobiotin complexation for controlled release of the antibody conjugate. Release was tuned by altering the total biotin derivative concentration without further hydrogel or antibody modification. First-order tunable release of bioactive Avastin, a therapeutic anti-VEGF antibody, was demonstrated from a non-cytotoxic system for over 100days.
引用
收藏
页码：3406 / 3410
页数：5
相关论文
共 42 条
  • [1] Biosensing with plasmonic nanosensors
    Anker, Jeffrey N.
    Hall, W. Paige
    Lyandres, Olga
    Shah, Nilam C.
    Zhao, Jing
    Van Duyne, Richard P.
    [J]. NATURE MATERIALS, 2008, 7 (06) : 442 - 453
  • [2] Engineered single-chain dimeric streptavidins with an unexpected strong preference for biotin-4-fluorescein
    Aslan, FM
    Yu, Y
    Mohr, SC
    Cantor, CR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (24) : 8507 - 8512
  • [3] Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis
    Ba, Jun
    Peng, Run-Sheng
    Xu, Ding
    Li, Yan-Hong
    Shi, Hui
    Wang, Qianyi
    Yu, Jing
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5397 - 5405
  • [4] Programmable Release of Multiple Protein Drugs from Aptamer-Functionalized Hydrogels via Nucleic Acid Hybridization
    Battig, Mark R.
    Soontornworajit, Boonchoy
    Wang, Yong
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (30) : 12410 - 12413
  • [5] Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2
    Bhakta, Gajadhar
    Rai, Bina
    Lim, Zophia X. H.
    Hui, James H.
    Stein, Gary S.
    van Wijnen, Andre J.
    Nurcombe, Victor
    Prestwich, Glenn D.
    Cool, Simon M.
    [J]. BIOMATERIALS, 2012, 33 (26) : 6113 - 6122
  • [6] Sustained-release ophthalmic drug delivery systems for treatment of macular disorders - Present and future applications
    Booth, Blake A.
    Denham, Lori Vidal
    Bouhanik, Saadallah
    Jacob, Jean T.
    Hill, James M.
    [J]. DRUGS & AGING, 2007, 24 (07) : 581 - 602
  • [7] Sensitivity studies for specific binding reactions using the biotin/streptavidin system by evanescent optical methods
    Busse, S
    Scheumann, V
    Menges, B
    Mittler, S
    [J]. BIOSENSORS & BIOELECTRONICS, 2002, 17 (08) : 704 - 710
  • [8] Potent antibody therapeutics by design
    Carter, PJ
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (05) : 343 - 357
  • [9] Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair
    Chen, William C. W.
    Lee, Brandon G.
    Park, Dae Woo
    Kim, Kyobum
    Chu, Hunghao
    Kim, Kang
    Huard, Johnny
    Wang, Yadong
    [J]. BIOMATERIALS, 2015, 72 : 138 - 151
  • [10] CHIGNELL CF, 1975, J BIOL CHEM, V250, P5622
12345